Abstract
Remission is the ultimate goal in the treatment of chronic pain, whereby the disease is mitigated to the point that patients can reach a normalized quality of life and activities of daily living following the elimination of symptoms. Although ≥50% pain relief (“responder”) is the benchmark for spinal cord stimulation (SCS) success in the treatment of chronic pain (2), there is precedence for reporting a higher responder rate (≥80% pain relief) (3,4). A recent technological advancement in spinal cord stimulation (SCS) has enabled measurement of the neurophysiological response to SCS (Evoked Compound Action Potentials [ECAPs]), confirmation of the intended target, and optimization of programming (open- and closed-loop mode), as well as maintenance of consistent activation (closed-loop mode only).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
